A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- Author
- DOODY, Rachelle S1 ; RAMAN, Rema2 3 ; AISEN, Paul S3 ; SIEMERS, Eric8 ; SETHURAMAN, Gopalan8 ; MOHS, Richard8 ; FARLOW, Martin9 ; IWATSUBO, Takeshi4 ; VELLAS, Bruno5 ; JOFFE, Steven6 ; KIEBURTZ, Karl7 ; FENG HE2 ; XIAOYING SUN2 ; THOMAS, Ronald G2 3
[1] Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, United States
[2] Division of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, University of California at San Diego, San Diego, United States
[3] Department of Neurosciences, University of California at San Diego, San Diego, United States
[4] Department of Neuropathology and Neuroscience, University of Tokyo, Tokyo, Japan
[5] Clinic of Internal Medicine and Gerontology, Hôpital La Grave-Casselardit, Toulouse, France
[6] Department of Hematology-Oncology, Boston Children's Hospital, Boston, United States
[7] Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, United States
[8] Eli Lilly and the Semagacestat Study Group, Indiana University, Indianapolis, United States
[9] Indiana Alzheimer Disease Center, Indiana University, Indianapolis, United States
Semagacestat Study Group - Source
The New England journal of medicine. 2013, Vol 369, Num 4, pp 341-350, 10 p ; ref : 24 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Démence d'Alzheimer Essai clinique phase III Médecine Traitement Maladie dégénérative Pathologie de l'encéphale Pathologie du système nerveux central Pathologie du système nerveux
- Keyword (en)
- Alzheimer disease Phase III trial Medicine Treatment Degenerative disease Cerebral disorder Central nervous system disease Nervous system diseases
- Keyword (es)
- Demencia Alzheimer Ensayo clínico fase III Medicina Tratamiento Enfermedad degenerativa Encéfalo patología Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C13 Organic mental disorders. Neuropsychology
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03M Organic mental disorders. Neuropsychology
- Discipline
- Generalities in medical sciences Neurology Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 27504675
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1210951 
https://dx.doi.org/10.1056/NEJMoa1210951
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"341\";s:8:\"\u0000*\u0000epage\";s:3:\"350\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DOODY\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Rachelle S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"RAMAN, Rema\";i:1;s:13:\"AISEN, Paul S\";i:2;s:13:\"SIEMERS, Eric\";i:3;s:19:\"SETHURAMAN, Gopalan\";i:4;s:13:\"MOHS, Richard\";i:5;s:14:\"FARLOW, Martin\";i:6;s:17:\"IWATSUBO, Takeshi\";i:7;s:13:\"VELLAS, Bruno\";i:8;s:13:\"JOFFE, Steven\";i:9;s:14:\"KIEBURTZ, Karl\";i:10;s:7:\"FENG HE\";i:11;s:12:\"XIAOYING SUN\";i:12;s:16:\"THOMAS, Ronald G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"341\";s:8:\"\u0000*\u0000epage\";s:3:\"350\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DOODY\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Rachelle S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"RAMAN, Rema\";i:1;s:13:\"AISEN, Paul S\";i:2;s:13:\"SIEMERS, Eric\";i:3;s:19:\"SETHURAMAN, Gopalan\";i:4;s:13:\"MOHS, Richard\";i:5;s:14:\"FARLOW, Martin\";i:6;s:17:\"IWATSUBO, Takeshi\";i:7;s:13:\"VELLAS, Bruno\";i:8;s:13:\"JOFFE, Steven\";i:9;s:14:\"KIEBURTZ, Karl\";i:10;s:7:\"FENG HE\";i:11;s:12:\"XIAOYING SUN\";i:12;s:16:\"THOMAS, Ronald G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"341\";s:8:\"\u0000*\u0000epage\";s:3:\"350\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DOODY\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Rachelle S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"RAMAN, Rema\";i:1;s:13:\"AISEN, Paul S\";i:2;s:13:\"SIEMERS, Eric\";i:3;s:19:\"SETHURAMAN, Gopalan\";i:4;s:13:\"MOHS, Richard\";i:5;s:14:\"FARLOW, Martin\";i:6;s:17:\"IWATSUBO, Takeshi\";i:7;s:13:\"VELLAS, Bruno\";i:8;s:13:\"JOFFE, Steven\";i:9;s:14:\"KIEBURTZ, Karl\";i:10;s:7:\"FENG HE\";i:11;s:12:\"XIAOYING SUN\";i:12;s:16:\"THOMAS, Ronald G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"341\";s:8:\"\u0000*\u0000epage\";s:3:\"350\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DOODY\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Rachelle S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"RAMAN, Rema\";i:1;s:13:\"AISEN, Paul S\";i:2;s:13:\"SIEMERS, Eric\";i:3;s:19:\"SETHURAMAN, Gopalan\";i:4;s:13:\"MOHS, Richard\";i:5;s:14:\"FARLOW, Martin\";i:6;s:17:\"IWATSUBO, Takeshi\";i:7;s:13:\"VELLAS, Bruno\";i:8;s:13:\"JOFFE, Steven\";i:9;s:14:\"KIEBURTZ, Karl\";i:10;s:7:\"FENG HE\";i:11;s:12:\"XIAOYING SUN\";i:12;s:16:\"THOMAS, Ronald G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1210951\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"341\";s:8:\"\u0000*\u0000epage\";s:3:\"350\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DOODY\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Rachelle S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"RAMAN, Rema\";i:1;s:13:\"AISEN, Paul S\";i:2;s:13:\"SIEMERS, Eric\";i:3;s:19:\"SETHURAMAN, Gopalan\";i:4;s:13:\"MOHS, Richard\";i:5;s:14:\"FARLOW, Martin\";i:6;s:17:\"IWATSUBO, Takeshi\";i:7;s:13:\"VELLAS, Bruno\";i:8;s:13:\"JOFFE, Steven\";i:9;s:14:\"KIEBURTZ, Karl\";i:10;s:7:\"FENG HE\";i:11;s:12:\"XIAOYING SUN\";i:12;s:16:\"THOMAS, Ronald G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:68:\"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
